| Q37193594 | A Case Report of an Invasive Infantile Fibrosarcoma of the Forearm |
| Q91902151 | A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive Treatment |
| Q42012238 | A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off. |
| Q60035737 | A Multiplex Real-Time PCR Assay for the Detection of Gene Fusions Observed in Solid Tumors |
| Q35752526 | A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma |
| Q40608574 | A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation |
| Q52800255 | A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report. |
| Q57055324 | A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes |
| Q54570630 | A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation. |
| Q38493837 | ALK probe rearrangement in a t(2;11;2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion: toward a molecular definition of an inflammatory myofibroblastic tumor family? |
| Q39343234 | AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts |
| Q42857007 | Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms |
| Q74545337 | Absence of t(12;15) associated ETV6-NTRK3 fusion transcripts in pediatric acute leukemias |
| Q59094227 | Absence of t(12;15) associatedETV6-NTRK3 fusion transcripts in pediatric acute leukemias |
| Q30168524 | Additional complexity on human chromosome 15q: identification of a set of newly recognized duplicons (LCR15) on 15q11-q13, 15q24, and 15q26. |
| Q88239553 | An active drug for TRK-positive paediatric solid tumours |
| Q91198223 | Ancillary testing in salivary gland cytology: A practical guide |
| Q51203259 | Angiomatoid fibrous histiocytoma: clinicopathological and molecular characterisation with emphasis on variant histomorphology. |
| Q46512789 | Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer |
| Q73572551 | Biological continuum of benign, atypical, and malignant mesenchymal neoplasms - does it exist? |
| Q28486949 | Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types |
| Q98829676 | Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions |
| Q35869194 | COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans |
| Q38353573 | Cancer genomics: why rare is valuable |
| Q34754889 | Cardiac metastasis and hypertrophic osteoarthropathy in recurrent infantile fibrosarcoma |
| Q73231046 | Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies |
| Q33875703 | Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes |
| Q42702851 | Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia |
| Q40808258 | Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma. |
| Q73270829 | Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein |
| Q38804690 | Chest Wall Infantile Fibrosarcomas- A Rare Presentation |
| Q54772462 | Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones. |
| Q34456861 | Chromosomal translocations in sarcomas: prospects for therapy |
| Q28236691 | Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)--associated TORC1-MAML2 gene fusion |
| Q36145215 | Clinical features of molecular pathology of solid tumours in childhood |
| Q44973480 | Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. |
| Q24631412 | Complex landscapes of somatic rearrangement in human breast cancer genomes |
| Q41038509 | Congenital Infantile Fibrosarcoma Causing Intestinal Perforation in a Newborn. |
| Q39026805 | Congenital infantile fibrosarcoma mimicking a cutaneous vascular lesion: a case report and review of the literature. |
| Q38242573 | Congenital infantile fibrosarcoma of the colon: a case series and literature review. |
| Q33411676 | Congenital infantile fibrosarcoma: Association with bleeding diathesis |
| Q34754714 | Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma |
| Q38487989 | Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis |
| Q33749267 | Current aspects of the pathology of soft tissue sarcomas |
| Q64103952 | Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance |
| Q81892355 | Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21 |
| Q73048179 | Cytogenetic findings in a case of nodular fasciitis of subclavicular region |
| Q34435769 | Cytopathologic features of mammary analogue secretory carcinoma |
| Q34323861 | Dependence receptor TrkC is a putative colon cancer tumor suppressor. |
| Q38336067 | Detecting and targetting oncogenic fusion proteins in the genomic era. |
| Q38412292 | Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features |
| Q38492004 | Detection of a novel t(6;15)(q21;q21) in a pediatric Wilms tumor |
| Q36272048 | Detection of fusion genes in sarcomas using paraffin-embedded tissues |
| Q33888796 | Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors |
| Q33799662 | Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours |
| Q27777801 | Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? |
| Q43078765 | Diagnostic value of neurotrophin expression in malignant pleural effusions |
| Q28215276 | Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression |
| Q33762257 | Directing oncogenic fusion genes into stem cells via an SCL enhancer |
| Q80637691 | Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type |
| Q22011151 | ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1 |
| Q37573395 | ETS gene fusions in prostate cancer |
| Q77351206 | ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization |
| Q36328085 | ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex |
| Q47234662 | ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study. |
| Q89030653 | ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition |
| Q37627018 | ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer |
| Q28217452 | ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation |
| Q92759869 | Early Surgery Is Feasible for a Very Large Congenital Infantile Fibrosarcoma Associated With Life Threatening Coagulopathy: A Case Report and Literature Review |
| Q47941750 | Emerging Opportunities for Target Discovery in Rare Cancers |
| Q26766271 | Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers |
| Q38800617 | Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model |
| Q48254756 | Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases. |
| Q34317033 | Ewing tumor: tumor biology and clinical applications |
| Q38461502 | Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans |
| Q34522849 | Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma |
| Q35632227 | Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer. |
| Q34160782 | Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma |
| Q54597920 | FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation. |
| Q64968312 | Fatal Course of Abdominal Neonatal Intestinal Fibrosarcoma. |
| Q37993925 | Fibroblastic and myofibroblastic tumors in children and adolescents |
| Q39514914 | Fibromatoses: clinical and pathological features suggestive of recurrence |
| Q60021317 | Fibrosarcoma and Its Variants |
| Q99546173 | Fine needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case series with predominantly indeterminate cytology |
| Q33838325 | Functional characterization of human cancer-derived TRKB mutations |
| Q39595452 | Fusion gene microarray reveals cancer type-specificity among fusion genes |
| Q79845854 | Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer |
| Q37353937 | Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment |
| Q38326452 | Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma |
| Q36398134 | Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. |
| Q44124498 | Gene expression of TrkC (NTRK3) in human soft tissue tumours |
| Q37234080 | Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes |
| Q36803632 | Gene translocations in musculoskeletal neoplasms |
| Q50445077 | Generalized infantile myofibromatosis with a monophasic primitive pattern. |
| Q98159763 | Genetic analysis in the clinical management of biliary tract cancer |
| Q89557124 | Genomic basis for RNA alterations in cancer |
| Q37384373 | Genomic characteristics of soft tissue sarcomas |
| Q42510239 | Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. |
| Q47720679 | Haemopoietic transformation by the TEL/ABL oncogene. |
| Q47665019 | Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia |
| Q92702627 | IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors |
| Q46229973 | Identification of NTRK fusions in pediatric mesenchymal tumors |
| Q51040335 | Identification of NTRK3 Fusions in Childhood Melanocytic Neoplasms. |
| Q37149773 | Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF |
| Q37259269 | Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers. |
| Q58080406 | Immunohistochemical Correlates of Recurrent Genetic Alterations in Sarcomas |
| Q37357286 | Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101. |
| Q46044924 | Infantile NTRK-associated Mesenchymal Tumors. |
| Q38110328 | Infantile fibrosarcoma-a clinical and histologic mimicker of vascular malformations: case report and review of the literature |
| Q54117764 | Inhibiting TRK Proteins in Clinical Cancer Therapy. |
| Q57154788 | Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application |
| Q89108056 | Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation |
| Q53625937 | Intestinal congenital/infantile fibrosarcoma: a new clinico-pathological entity? |
| Q92891966 | Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion |
| Q53344487 | MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice. |
| Q97536811 | MR imaging findings of a rare pediatric parotid tumor: Mammary analogue secretory carcinoma |
| Q33676375 | Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases |
| Q36276161 | Mammary analog secretory carcinoma of the parotid gland: A case report and literature review. |
| Q37248485 | Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion |
| Q33946147 | Mechanisms of transformation by the BCR/ABL oncogene |
| Q97568917 | Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST) |
| Q36441147 | Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH). |
| Q46721493 | Mixed epithelial and stromal tumor of the kidney in a 12-year-old girl |
| Q24648208 | Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9 |
| Q38964224 | Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay. |
| Q38588243 | Molecular basis of differentiation therapy for soft tissue sarcomas |
| Q34174026 | Molecular biology of the Ets family of transcription factors |
| Q91842359 | Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours |
| Q37758279 | Molecular classification of soft tissue sarcomas and its clinical applications |
| Q38495279 | Molecular cytogenetic study of a hemangiopericytoma in a newborn |
| Q38378763 | Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors |
| Q35064137 | Molecular genetic diagnosis of pediatric cancer: current and emerging methods |
| Q35183100 | Molecular genetics of pediatric soft tissue tumors: clinical application |
| Q26829833 | Molecular mechanisms of ETS transcription factor-mediated tumorigenesis |
| Q37183461 | Molecular pathology and potential therapeutic targets in soft-tissue sarcoma |
| Q33747747 | Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review). |
| Q54507966 | Morphologic Overlap between Infantile Myofibromatosis and Infantile Fibrosarcoma: A Pitfall in Diagnosis. |
| Q30371733 | Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma |
| Q34726784 | Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas |
| Q42149962 | Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation |
| Q38363342 | Mutational analysis of ETV6 in prostate carcinoma |
| Q34181347 | Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity |
| Q52535512 | Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia. |
| Q35790440 | Myofibrosarcoma |
| Q51733074 | NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. |
| Q92924197 | NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target |
| Q100962839 | NTRK and Other Recently Described Kinase Fusion Positive Uterine Sarcomas: a Review of a Group of Rare Neoplasms |
| Q92377719 | NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls |
| Q58547264 | NTRK fusion-positive cancers and TRK inhibitor therapy |
| Q28066821 | NTRK gene fusions as novel targets of cancer therapy across multiple tumour types |
| Q42709455 | NTRK3 kinase fusions in Spitz tumours |
| Q24801634 | Native interface of the SAM domain polymer of TEL. |
| Q94337737 | Neonate with a fibrosarcoma and consumptive coagulopathy |
| Q34548702 | Newly described salivary gland tumors |
| Q54355092 | Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. |
| Q33739715 | Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma. |
| Q49388791 | Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis |
| Q88673669 | Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals |
| Q26768158 | Oncogenic kinase fusions: an evolving arena with innovative clinical opportunities |
| Q34476916 | Orthopaedic case of the month: Rapidly progressive shoulder soft tissue mass in an 8-week-old girl |
| Q52885342 | Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern. |
| Q34581647 | Part I: Primary malignant non-Wilms' renal tumours in children |
| Q73804715 | Pediatric soft tissue sarcomas |
| Q43431904 | Philadelphia chromosome-like acute lymphoblastic leukemia |
| Q27633822 | Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression |
| Q37291219 | Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies |
| Q34229580 | RNA-Seq mapping and detection of gene fusions with a suffix array algorithm |
| Q38730141 | Rare cancers: a sea of opportunity |
| Q36016101 | Re-evaluating historic cohort of salivary acinic cell carcinoma with new diagnostic tools |
| Q52897655 | Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. |
| Q47649693 | Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma |
| Q48368768 | Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. |
| Q34421273 | Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma |
| Q48151927 | Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand? |
| Q82487144 | Recurrent and metastatic infantile fibrosarcoma: a case report |
| Q37164587 | Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications |
| Q38423806 | Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples. |
| Q33834965 | Regular review: tumour markers in malignancies |
| Q38742012 | Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine |
| Q90262410 | Revisiting NTRKs as an emerging oncogene in hematological malignancies |
| Q34514095 | Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification |
| Q92633091 | Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer |
| Q92785094 | S100 and CD34 positive spindle cell tumor with prominent perivascular hyalinization and a novel NCOA4-RET fusion |
| Q28550973 | SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier |
| Q41636361 | Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1). |
| Q50871807 | Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics. |
| Q90626667 | Secretory Carcinoma of the Thyroid Gland: Report of a Highly Aggressive Case Clinically Mimicking Undifferentiated Carcinoma and Review of the Literature |
| Q42444988 | Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum |
| Q47780430 | Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis |
| Q90224381 | Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential |
| Q90789211 | Secretory carcinoma of the major salivary gland: Provincial population-based analysis of clinical behavior and outcomes |
| Q34768432 | Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. |
| Q34486039 | Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia |
| Q28469179 | Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma |
| Q58707604 | Soft Tissue Sarcoma Cancer Stem Cells: An Overview |
| Q37461034 | Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations |
| Q37638352 | Soft tissue tumors associated with EWSR1 translocation. |
| Q57727275 | Solitary, multifocal and generalized myofibromas: clinicopathological and immunohistochemical features of 114 cases |
| Q22010632 | TEL is a sequence-specific transcriptional repressor |
| Q40795252 | TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway |
| Q24669567 | TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors |
| Q28254287 | TRKing down an old oncogene in a new era of targeted therapy |
| Q38917380 | TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation |
| Q34314927 | Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia |
| Q37975246 | Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy |
| Q40842655 | Tel induces a G1 arrest and suppresses Ras-induced transformation |
| Q40452513 | Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components. |
| Q34132159 | The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor |
| Q33892265 | The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells |
| Q39540235 | The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. |
| Q40235633 | The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation. |
| Q38981486 | The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition. |
| Q36344275 | The comparative roles of electron microscopy and immunohistochemistry in the diagnosis of soft tissue tumours |
| Q36654494 | The dark side of the NGF family: neurotrophins in neoplasias |
| Q28291406 | The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation |
| Q35035289 | The evolutionary chromosome translocation 4;19 in Gorilla gorilla is associated with microduplication of the chromosome fragment syntenic to sequences surrounding the human proximal CMT1A-REP |
| Q38359543 | The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma |
| Q33881163 | The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation |
| Q43241596 | The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. |
| Q34437602 | The landscape of kinase fusions in cancer |
| Q42177224 | The molecular biology of soft-tissue sarcomas and current trends in therapy |
| Q33884178 | The oncogenic TLS-ERG fusion protein exerts different effects in hematopoietic cells and fibroblasts |
| Q38735300 | The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer. |
| Q34267620 | The receptor tyrosine kinases: role in cancer progression. |
| Q36344267 | The role of genetic testing in soft tissue sarcoma |
| Q36069772 | The spectrum of pediatric fibroblastic and myofibroblastic tumors |
| Q35801750 | The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. |
| Q78427194 | The utility of spectral karyotyping in the cytogenetic analysis of newly diagnosed pediatric acute lymphoblastic leukemia |
| Q38816769 | Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST. |
| Q40722826 | Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG. |
| Q37363960 | Translocations in epithelial cancers |
| Q33368676 | Translocations, cancer and the puzzle of specificity |
| Q34549157 | Trk receptor expression and inhibition in neuroblastomas |
| Q38940598 | TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts |
| Q40124461 | TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling |
| Q53295813 | TrkC plays an essential role in breast tumor growth and metastasis. |
| Q37462530 | TrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1. |
| Q24299955 | TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior |
| Q35589206 | Tyrosine kinase inhibitors as cancer therapy |
| Q26999088 | Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands |
| Q90344247 | Update on systemic therapy for advanced soft-tissue sarcoma |
| Q34500797 | Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma |
| Q36964314 | Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer |
| Q81563871 | [Fibroblastic-myofibroblastic proliferations of childhood and adolescents] |
| Q34077476 | t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia |
| Q42798686 | v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6). |